New research shows that in patients with psoriasis, even though their skin responds well to treatment with biologics, ...

Ascletis Pharma Inc. (HKEX:1672, "Ascletis") announces the U.S. Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for a Phase I trial for ASC50 for the ...

A new study reveals psoriasis may increase the risk of obesity and fatty liver despite skin improvements Learn why managing inflammation beyond the skin is essential ...

Residual inflammation persisted among patients with psoriasis despite optimal disease response to biologic therapies, putting ...

Learn to distinguish between nail psoriasis and nail fungus through key visual differences, associated symptoms, and ...

Stull said that a number of prescription treatments exist for topical psoriasis, such as steroids and injectable therapies, ...

Skin symptoms may clear with biologics in psoriasis, but hidden internal inflammation often persists, contributing to major ...

Roflumilast foam, 0.3%, proved to be a simplified treatment regimen with high efficacy for patients with scalp and body ...

Risk for the autoimmune hair disorder was reduced by nearly 75% in patients on these treatments for psoriasis, finds a ...

Johnson & Johnson (J&J) has reported new data from the Phase III ICONIC-TOTAL trial, assessing icotrokinra in treating plaque ...